Status:
UNKNOWN
Periodontal Therapy on the Gut Microbiome of Inflammatory Bowel Disease
Lead Sponsor:
University of Turin, Italy
Conditions:
Periodontal Diseases
IBD
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Periodontitis and inflammatory bowel disease have been associated by meta-epidemiologic evidence, although their mechanistic connection needs to be further explored. Oral-gut axis is implicated in the...
Eligibility Criteria
Inclusion
- clinical and instrumental diagnosis of ulcerative colitis or Crohn's disease
- periodontitis Stage III or IV
- BMI between 20 and 29 kg/m2
- free diet
- presence of at least 20 teeth
Exclusion
- Systemic diseases (including diabetes, thyroid, liver, or kidney diseases)
- dietary allergies
- use of antibiotics or probiotics during the previous 30 days
- pregnancy or breast feeding
Key Trial Info
Start Date :
May 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04790825
Start Date
May 2 2021
End Date
May 15 2023
Last Update
November 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CIR Dental School
Turin, Italy, 10126